TNF and Cirrhosis: Due to multiple hospitalizations with refractoriness to treatment with mesalazine, hematological side effects of azathioprine, side effects of corticosteroid use, and the risk of serious infection in patients with cirrhosis, we opted for the use of infliximab, an anti-TNF biological therapy.